http://www.buffalo.edu/news/list-page.html?key=ub2020-molecular en-US Copyright 2008, University at Buffalo 2008-05-12T16:38:14-04:00 apage@buffalo.edu apage@buffalo.edu http://www.buffalo.edu/news/9189 A powerful air sterilization technology developed at the University at Buffalo has killed every biological agent with which it has been challenged, including airborne spores, viruses and bacteria in independent tests conducted for the U.S. Department of Defense. 2008-02-28T00:00:00-04:00 91890009 http://www.buffalo.edu/news/9128 Two novel proteins studied by a University at Buffalo professor of microbiology and immunology appear to have the potential to enhance the production of antibodies against a multitude of infectious agents. 2008-02-05T00:00:00-04:00 91280009 http://www.buffalo.edu/news/9097 A new chemical synthesis method based on a catalyst worth many times the price of gold and providing a far more efficient and economical method than traditional ones for designing and manufacturing extremely novel pharmaceutical compounds is described by its University at Buffalo developers in a review article in the current issue of <i>Nature</i>. 2008-01-23T00:00:00-04:00 90970009 http://www.buffalo.edu/news/9077 A $1 million gift to the University at Buffalo School of Engineering and Applied Sciences from a global industry leader with a strong interest in Western New York will be used for costs associated with the construction of a new, high-tech engineering building on UB's North (Amherst) Campus. 2008-01-18T00:00:00-04:00 90770009 http://www.buffalo.edu/news/9078 In an effort to improve this process and develop new guidelines for antibiotic use for a potentially deadly staph infection, University at Buffalo researchers are collecting bacterial isolates and clinical information from SAB-infected patients hospitalized in three area hospitals and following their charted progress through inpatient treatment, discharge and for a post-discharge period. 2008-01-18T00:00:00-04:00 90780009 http://www.buffalo.edu/news/9003 A discovery by University at Buffalo biologists that may explain the evolution of a lethal toxin is providing new information that could lead to more effective treatments for humans who fall victim to it. 2007-12-03T00:00:00-04:00 90030009 http://www.buffalo.edu/news/8983 An anti-cancer drug developed by Kinex Pharmaceuticals of Buffalo and a University at Buffalo faculty researcher has begun clinical testing with patients. 2007-11-16T00:00:00-04:00 89830009 http://www.buffalo.edu/news/8954 A $148,328 grant from the John R. Oishei Foundation will establish a multidisciplinary task force for ontology-based IT support for large-scale field studies in psychiatry at the University at Buffalo. 2007-11-05T00:00:00-04:00 89540009 http://www.buffalo.edu/news/8902 A professor of biochemistry in the School of Medicine and Biomedical Sciences at the University at Buffalo, has received a two-year, $418,363 grant from the National Institutes of Health to develop a drug aimed at an iron-based neurodegenerative disease called aceruloplasminemia. 2007-10-16T00:00:00-04:00 89020009 http://www.buffalo.edu/news/8841 The National Institutes of Health Center for Scientific Review has appointed Robert M. Straubinger, professor in the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, to serve as a member of its Drug Discovery and Molecular Pharmacology Study Section. 2007-09-17T00:00:00-04:00 88410009